Ex vivo-expanded DCs induce donor-specific central and peripheral tolerance and prolong the acceptance of donor skin grafts

Blood

Volumn 117, Issue 9, 2011, Pages 2640-2648

  Yamano, Tomoyoshi ^a   Watanabe, Sho ^a   Hasegawa, Hiroyuki ^a   Suzuki, Toshihiro ^a   Abe, Ryo ^a   Tahara, Hideaki ^b   Nitta, Takeshi ^c   Ishimaru, Naozumi ^c   Sprent, Jonathan ^d,e   Kishimoto, Hidehiro ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; BONE MARROW; CONTROLLED STUDY; DENDRITIC CELL; EX VIVO STUDY; FEMALE; HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; T LYMPHOCYTE; THYMOCYTE; THYMUS;

EID: 79953093084     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-07-293860     Document Type: Article

References (46)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245-252. (Pubitemid 28155090)
2. Villadangos JA, Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol. 2007;7(7):543-555. (Pubitemid 46987783)
3. Steinman R, Hawiger D, Nussenzweig M. Tolerogenic dendritic cells. Annu Rev Immunol. 2003;21:685-711. (Pubitemid 37174545)
4. Klein L, Hinterberger M, Wirnsberger G, Kyewski B. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol. 2009;9(12):833-844.
5. Palmer E. Negative selection-clearing out the bad apples from the T-cell repertoire. Nat Rev Immunol. 2003;3(5):383-391. (Pubitemid 37323198)
6. Sprent J, Kishimoto H. The thymus and negative selection. Immunol Rev. 2002;185:126-135. (Pubitemid 34994936)
7. Le Borgne M, Ladi E, Dzhagalov I, et al. The impact of negative selection on thymocyte migration in the medulla. Nat Immunol. 2009;10(8):823-830.
8. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol. 2004;5(12):1219-1226. (Pubitemid 41057736)
9. Lahoud MH, Proietto AI, Gartlan KH, et al. Signal regulatory protein molecules are differentially expressed by CD8(-) dendritic cells. J Immunol. 2006;177(1):372-382. (Pubitemid 43939149)
10. Li JC, Park J, Foss D, Goldschneider I. Thymushoming peripheral dendritic cells constitute two of the three major subsets of dendritic cells in the steady-state thymus. J Exp Med. 2009;206(3):607-622.
11. Tacken PJ, de Vries IJM, Torensma R, Figdor CG. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol. 2007;7(10):790-802. (Pubitemid 47480309)
12. Lutz MB, Kukutsch N, Ogilvie ALJ, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999;223(1):77-92. (Pubitemid 29096240)
13. Brasel K, De Smedt T, Smith JL, Maliszewski CR. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood. 2000;96(9):3029-3039.
14. Xu YK, Zhan YF, Lew AM, Naik SH, Kershaw MH. Differential development of murine dendritic cells by GM-CSF versus flt3 ligand has implications for inflammation and trafficking. J Immunol. 2007;179(11):7577-7584.
15. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol. 2007;7(1):19-30. (Pubitemid 46020824)
16. Naik SH, Proietto AI, Wilson NS, et al. Cutting edge: Generation of splenic CD8(+) and CD8(-) dendritic cell equivalents in fms-like tyrosine kinase 3 ligand bone marrow cultures. J Immunol. 2005;174(11):6592-6597. (Pubitemid 40705619)
17. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol. 2007;7(8):610-621. (Pubitemid 47123548)
18. Hawiger D, Inaba K, Dorsett Y, et al. Dendritic cells induce peripheral T-cell unresponsiveness under steady state conditions in vivo. J Exp Med. 2001;194(6):769-779. (Pubitemid 32983013)
19. Roncarolo MG, Levings MK, Traversari C. Differentiation of T regulatory cells by immature dendritic cells. J Exp Med. 2001;193(2):F5-F9. (Pubitemid 32524446)
20. Lane P, Gerhard W, Hubele S, Lanzavecchia A, McConnell F. Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human gamma 1. Immunology. 1993;80(1):56-61. (Pubitemid 23284188)
21. Habiro K, Shimmura H, Kobayashi S, et al. Effect of inflammation on costimulation blockade-resistant allograft rejection. Am J Transplant. 2005;5(4):702-711. (Pubitemid 40461279)
22. Young KJ, Yang LM, Phillips MJ, Zhang L. Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells. Blood. 2002;100(9):3408-3414. (Pubitemid 35217094)
23. Vascotto F, Le Rouz D, Lankar D, et al. Antigen presentation by B lymphocytes: how receptor signaling directs membrane trafficking. Curr Opin Immunol. 2007;19(1):93-98. (Pubitemid 46073700)
24. Gallegos A, Bevan M. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J Exp Med. 2004;200(8):1039-1049. (Pubitemid 39431128)
25. Lutz MB, Suri RM, Niimi M, et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol. 2000;30(7):1813-1822. (Pubitemid 30456177)
26. Markees TG, Phillips NE, Gordon EJ, et al. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferongamma, and CTLA4. J Clin Invest. 1998;101(11):2446-2455. (Pubitemid 28270439)
27. Martin S, Bevan MJ. Antigen-specific and nonspecific deletion of immature cortical thymocytes caused by antigen injection. Eur J Immunol. 1997;27(10):2726-2736. (Pubitemid 27453867)
28. Sykes M. Mixed chimerism and transplant tolerance. Immunity. 2001;14(4):417-424. (Pubitemid 32441594)
29. Starzl TE. Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A. 2004;101(suppl 2):14607-14614. (Pubitemid 39346731)
30. Kean LS, Gangappa S, Pearson TC, Larsen CP. Transplant tolerance in non-human primates: Progress, current challenges and unmet needs. Am J Transplant. 2006;6(5):884-893. (Pubitemid 44356638)
31. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449(7161):419-426. (Pubitemid 47509552)
32. Walsh PT, Taylor DK, Turka LA. Tregs and transplantation tolerance. J Clin Invest. 2004;114(10):1398-1403. (Pubitemid 40385567)
33. Bonasio R, Scimone M, Schaerli P, Grabie N, Lichtman A, von Andrian U. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol. 2006;7(10):1092-1100. (Pubitemid 44420654)
34. Laszik Z, Jansen PJ, Cummings RD, Tedder TF, McEver RP, Moore KL. P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood. 1996;88(8):3010-3021. (Pubitemid 26357383)
35. Udaka K, Wiesmuller KH, Kienle S, Jung G, Walden P. Self-MHC-Restricted peptides recognized by an alloreactive T lymphocyte clone. J Immunol. 1996;157(2):670-678. (Pubitemid 26231370)
36. Suchin EJ, Langmuir PB, Palmer E, Sayegh MH, Wells AD, Turka LA. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol. 2001;166(2):973-981. (Pubitemid 32060253)
37. Larsen C, Elwood E, Alexander D, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 1996;381(6581):434-438. (Pubitemid 26162734)
38. Demirci G, Amanullah F, Kewalaramani R, et al. Critical role of OX40 in CD28 and CD154-independent rejection. J Immunol. 2004;172(3):1691-1698. (Pubitemid 38116817)
39. Durham M, Bingaman A, Adams A, et al. Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J Immunol. 2000;165(1):1-4. (Pubitemid 30429481)
40. Villadangos JA, Young L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity. 2008;29(3):352-361.
41. Birnberg T, Bar-On L, Sapoznikov A, et al. Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome. Immunity. 2008;29(6):986-997.
42. Ohnmacht C, Pullner A, King SBS, et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med. 2009;206(3):549-559.
43. Duncan S, Capetanakis N, Lawson B, Theofilopoulos A. Thymic dendritic cells traffic to thymi of allogeneic recipients and prolong graft survival. J Clin Invest. 2002;109(6):755-764. (Pubitemid 34263152)
44. Ochando JC, Homma C, Yang Y, et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol. 2006;7(6):652-662. (Pubitemid 43797347)
45. Liu C, Wang Q, Liu F, et al. The allogeneic but not syngeneic dendritic cells effectively generated regulatory T cells from total CD4+ population without exogenous cytokines. Scand J Immunol. 2010;71(1):12-19.
46. Brossart P, Grunebach F, Stuhler G, et al. Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor. Blood. 1998;92(11):4238-4247. (Pubitemid 28544340)